Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Leonardo Llamas-López"'
Autor:
Sergio Sauri-Suárez, Sandra Quiñones-Aguilar, Arturo Contreras-Marín, Erik Omar Ramiro-Guerrero, David Zúñiga-García, Leticia Salinas-Vázquez, Leonardo Llamas-López, Carolina León-Jiménez, Adriana García-Martell, Iliana González-Hernández, Erwin Chiquete, Silvia García
Publikováno v:
PLoS ONE, Vol 15, Iss 4, p e0230959 (2020)
BackgroundAdherence to disease-modifying therapies is determinant to attain maximal clinical benefit in multiple sclerosis (MS). RebiSmart® is an electronic auto-injector for subcutaneous delivery of interferon β-1a (INF-β1a) that monitors adheren
Externí odkaz:
https://doaj.org/article/e050786ee9624372b11d50b8c41371f0
Autor:
Sandra Quiñones-Aguilar, Verónica Rivas-Alonso, Gloria de Lourdes Llamosa García Velázquez, Marco Antonio Santos-Diaz, José Flores-Rivera, Victor Gonzalez-Amezquita, Manuel De la Maza-Flores, Carolina León-Jiménez, Zaira Medina-López, Miguel Ángel Macías-Islas, Brenda Bertado-Cortés, Laura Ordoñez-Boschetti, Eli Skromne-Eisenberg, Irene Treviño-Frenk, Jair Fernando Ortiz-Maldonado, Leonardo Llamas-López
Publikováno v:
Multiple sclerosis and related disorders. 53
Background Multiple sclerosis affects more than 2 million people. Clinical decisions are performed under evidence-based medicine. The appearance of new disease-modifying therapies and changes in diagnostic criteria complicates the decision-making pro
Publikováno v:
Alzheimer's & Dementia. 16
Autor:
Irene Treviño-Frenk, Eli Skromne-Eisenberg, Verónica Rivas-Alonso, Manuel De la Maza-Flores, Luis Enrique Amaya-Sánchez, Merced Velázquez-Quintana, Laura Ordoñez-Boschetti, Leonardo Llamas-López, Brenda Bertado-Cortés, Sandra Quiñones-Aguilar, Victor Gonzalez-Amezquita
Publikováno v:
Revista Mexicana de Neurociencia. 21
Autor:
Leticia Salinas-Vázquez, Leonardo Llamas-López, Sergio Sauri-Suárez, David Gilberto Zúñiga-García, Silvia García, Erik Omar Ramiro-Guerrero, Adriana García-Martell, Arturo Contreras-Marín, Carolina León-Jiménez, Iliana Fabiola González-Hernández, Sandra Quiñones-Aguilar, Erwin Chiquete
Publikováno v:
PLoS ONE, Vol 15, Iss 4, p e0230959 (2020)
PLoS ONE
PLoS ONE
BackgroundAdherence to disease-modifying therapies is determinant to attain maximal clinical benefit in multiple sclerosis (MS). RebiSmart® is an electronic auto-injector for subcutaneous delivery of interferon β-1a (INF-β1a) that monitors adheren
Autor:
Efraín, Gaxiola, Luis, Eng-Ceceña, Fernando, Ortiz-Galván, Leonardo, Llamas-López, Ricardo, Rangel-Guerra, Marco A, Alcocer-Gamba, Deepak L, Bhatt, P, Gabriel Steg, Jorge, Villarreal
Publikováno v:
Clinical cardiology. 33(7)
Background Atherothrombosis, a generalized and progressive process, is currently a major healthcare problem in Mexico. Methods The worldwide Reduction of Atherothrombosis for Continued Health (REACH) registry aimed to evaluate risk factors for athero